Skip to content
Home/Companies/Biotech/bit.bio
BB

bit.bio

Biotech·United Kingdom·Active·7yr hold

bit.bio is a biotech company, headquartered in United Kingdom.

Entry
2019
Hold
7yr
Status
Active
Est. EV
–

Who owns bit.bio?

bit.bio is currently owned by BlueYard Capital through BlueYard Capital Fund II (2019 vintage), since 2019.

Hand-verified · updated 2026-07-17

BlueYard Capital
Investor
BlueYard Capital
BlueYard Capital Fund II · 2019 · VC

Key facts

HQUnited Kingdom
SectorBiotech
StatusActive

More from BlueYard Capital Fund II

Other portfolio companies in the same fund.

Dance
Exited 2026
MobilityGermany· 2020
to
Insempra
Active
BiotechGermany· 2020
SEEQC
Active
Deep TechUnited States· 2020
Transcripta Bio
Active
BiotechUnited States· 2020
Grid
Active
SoftwareIceland· 2019
Marvel Fusion
Active
EnergyGermany· 2019

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Adcendo
Active
Jeito CapitalDenmark· 2026
Data refreshed weekly · Sourced from public filings